Medtronic 2016 Annual Report Download - page 140

Download and view the complete annual report

Please find page 140 of the 2016 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 158

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158

Table of Contents
Medtronic plc
Notes to Consolidated Financial Statements (Continued)
137
Consolidating Statement of Comprehensive Income
Fiscal Year Ended April 29, 2016
CIFSA Senior Notes
(in millions)
Parent
Company
Guarantor
(Medtronic
plc)
Subsidiary
Issuer
(CIFSA) Subsidiary
Guarantors
Subsidiary
Non-
guarantors Consolidating
Adjustments Total
Net sales $ — $ — $ — $ 28,833 $ — $ 28,833
Costs and expenses:
Cost of products sold 9,142 9,142
Research and development expense 2,224 2,224
Selling, general, and administrative
expense 10 1 3 9,455 — 9,469
Special (gains) charges, net 70 70
Restructuring charges, net 290 290
Certain litigation charges, net 26 26
Acquisition-related items 283 283
Amortization of intangible assets 1,931 1,931
Other (income) expense, net 112 1 (18) 12 — 107
Operating profit (loss) (122) (2) 15 5,400 — 5,291
Interest income (434)(710)(451) 1,164 (431)
Interest expense 25 138 10 2,377 (1,164) 1,386
Interest (income) expense, net 25 (296)(700) 1,926 955
Equity in net (income) loss of
subsidiaries (3,676) (8,563)(2,961) — 15,200
Income (loss) from operations before
income taxes 3,529 8,857 3,676 3,474 (15,200) 4,336
Provision (benefit) for income taxes (9) — 807 — 798
Net income (loss) 3,538 8,857 3,676 2,667 (15,200) 3,538
Other comprehensive income (loss), net
of tax (684) (102)(684)(684) 1,470 (684)
Total comprehensive income (loss) $ 2,854 $ 8,755 $ 2,992 $ 1,983 $ (13,730) $ 2,854